Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.

Vaccine
George KrashiasQuentin J Sattentau

Abstract

Carbopol is a polyanionic carbomer gel used in man for a variety of topical applications and drug delivery purposes. Here we show that subcutaneous administration of carbopol with glycoprotein antigens elicits unusually strong specific adaptive immune responses in mice. Recombinant soluble HIV-1 envelope glycoprotein (Env)-based antigen formulated in carbopol was at least as potent at stimulating Env-specific B and T cell responses as Freund's Complete Adjuvant, and significantly more potent than aluminium salts. The antigen-specific T cell immune response elicited both Th1 and Th2 cytokines including high titers of IFN-gamma, IL-2 and IL-4, and drove a Th1 isotype-switched antibody response. Mice immunized with a low dose of purified influenza HA in carbopol generated high titers of anti-HA antibodies and were protected from lethal challenge and disease with live virus. Similarly, immunization of mice with the melanoma cell line B16F10 formulated in carbopol significantly delayed tumor growth. We propose that carbopol, or related cross-linked polyacrylic acid analogues, may have promise for use as systemic vaccine adjuvants in man.

References

Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J J Skehel, M D Waterfield
Mar 1, 1974·European Journal of Immunology·R DörriesE Wecker
Jul 1, 1995·The Journal of Experimental Medicine·Q J Sattentau, J P Moore
Apr 1, 1994·Epidemiology and Infection·J A MumfordD M Jessett
Sep 9, 1999·The Journal of Infectious Diseases·B P ArulanandamD W Metzger
Nov 24, 1999·Immunological Reviews·J SchneiderA V Hill
Feb 15, 2001·AIDS Research and Human Retroviruses·C M RodenburgUNKNOWN UNAIDS and NIAID Networks for HIV Isolation and Characterization
Oct 26, 2002·Cancer Cell·Anna Katharina SimonGavin R Screaton
Feb 8, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·I K M LiuM P Morales-Levy
Apr 7, 2005·Nature Medicine·Achal PashineJeffrey B Ulmer
Feb 25, 2006·Cell·Daniel C DouekGary J Nabel
Nov 30, 2007·Current HIV Research·Shuji Sato, Welkin Johnson
Jan 17, 2008·Nature Reviews. Microbiology·Gunilla B Karlsson HedestamRichard T Wyatt
Mar 8, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lev Bromberg
Oct 1, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Kerriann Greenhalgh, Edward Turos
Nov 15, 2008·Annual Review of Immunology·Michael Dougan, Glenn Dranoff
Feb 13, 2009·Trends in Immunology·Dirk WerlingTracey J Coffey
Feb 28, 2009·Current Opinion in Immunology·Bart N LambrechtHamida Hammad
Mar 3, 2009·Science·Damian C EkiertIan A Wilson
Mar 17, 2009·Current Opinion in Immunology·Pawel Muranski, Nicholas P Restifo
Jun 6, 2009·Current Opinion in Immunology·Ennio De GregorioAndreas Wack
Jun 9, 2009·Current Opinion in Immunology·Shan Lu

❮ Previous
Next ❯

Citations

Jan 22, 2013·Annual Review of Immunology·Davide Corti, Antonio Lanzavecchia
Aug 4, 2011·Protein Engineering, Design & Selection : PEDS·Sara PruzinaMichael S Neuberger
Aug 28, 2012·Nature Biotechnology·Frank WegmannQuentin J Sattentau
Nov 29, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·J F S MannP F McKay
Oct 31, 2017·Asian Pacific Journal of Tropical Medicine·Adil M AllahverdiyevZeynep Akdeste
Aug 11, 2020·International Journal of Pharmaceutics: X·Marie GarinotJean Haensler
Jul 2, 2021·Veterinary Research·Evelien BiebautDominiek Maes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.